The monthly nonfarm payrolls report takes the spotlight next week as investors continue to look for guidance on the timing of an interest rate hike.» Read More
From Dow Chemical to Domino's Pizza, CEOs tell "Mad Money" host Jim Cramer how cheap crude is fueling new gains
"Mad Money" host Jim Cramer on why it's all eyes on the Oracle of Omaha.
Golden call on miners. Has gold found its mojo? With CNBC's Melissa Lee and the Options Action traders.
Netflix nears an all-time high. Are more gains in store? With CNBC's Melissa Lee and the Options Action traders.
Is it time to sell into the Nasdaq run? Will tech be different this time, with CNBC's Melissa Lee and the Options Action traders.
CNBC's Eric Chemi details sports stocks investors should be on the lookout for.
The Fast Money traders share their final trades of the day.
The Fast Money traders take a look at today's biggest market movers.
Monster Beverages has room to run, says Mark Astrachan, Stifel Nicolaus analyst, while discussing whether Coke should buy the company.
The "Fast Money" traders give their best buys for March.
Dissecting where to make money in this market, with the Fast Money traders.
Jeff Hirsch, The Stock Trader's Almanac, and CNBC Senior Contributor Larry Kudlow discuss the psychological importance of March for the Nasdaq.
Sen. Orrin Hatch's comments on tax reform, with CNBC's John Harwood.
Chris Whalen, Kroll Bond Rating Agency; Marc Lopestri, Lopestri Law Group; FM trader Steve Grasso; and CNBC's Robert Frank dissect this month's market action and the expected raising of interest rates.
Discussing current market conditions, with David Darst, Independent Investment consultant, and Joe Zicherman, JW Partners, who is really cautious.
According to research from Bespoke Investment Group, less than 7 percent of all analyst ratings are to sell, with the rest fairly evenly split between buy and hold. CNBC's Jeff Cox reports.
Discussing the outlook for stocks as the Nasdaq approaches 5,000, with Dorothy Rauschelbach, BetterInvesting; Susan Noyes, Makeitbetter.net; and Kristen Ruby, Ruby Media Group.
Outlining reasons the Fed may be ready to raise rates, Stanley Fischer, Federal Reserve Vice Chairman, says there is a strong possibility for a hike in 2015, with CNBC's Steve Liesman.
Eric Schmidt, Cowen & Co. biotech analyst, thinks biotech will continue to be a great business and will move higher. Insight, with Geoff Porges, Sanford Bernstein.
Dissecting the week of trading and the impact of the Fed and dollar, with Rob Morgan, Sethi Financial Group; D.R. Barton Jr., Moneymorning.com; Beth Ann Bovino, S&P; Mike Pequeen, Hightower and CNBC's Rick Santelli.